Towards the targeted modulation of gene expression by modified triplex-forming oligonucleotides

Current Chemical Biology

Volumn 2, Issue 1, 2008, Pages 1-10

  Rusling, David A ^a   Broughton Head, Victoria J ^a   Brown, Tom ^a   Fox, Keith R ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

DNA sequences; Gene Expression; yeast systems; Parallel triplexes; Transcription Initiation

Indexed keywords

DOUBLE STRANDED DNA; NUCLEIC ACID; OLIGONUCLEOTIDE; RNA POLYMERASE;

BINDING AFFINITY; BIOTECHNOLOGY; CELL NUCLEUS; CHEMICAL MODIFICATION; CHEMICAL STRUCTURE; DNA BINDING; DNA REPLICATION; DNA SEQUENCE; DNA STRUCTURE; GENE ACTIVITY; GENE EXPRESSION; GENE INACTIVATION; GENE TARGETING; HUMAN; NONHUMAN; PH; PRIORITY JOURNAL; REVIEW; RNA TRANSLATION; TRANSCRIPTION INITIATION;

EID: 41749092321     PISSN: 18723136     EISSN: None     Source Type: Journal    
DOI: 10.2174/187231308783334135     Document Type: Review

References (139)

1. Felsenfeld G, Davies DR, Rich A. Formation of a three-stranded polynucleotide molecule. J Am Chem Soc 1957; 79: 2023-20.
2. Moser HE, Dervan PB. Sequence specific cleavage of double-helical DNA by triple helix formation. Science 1987; 238: 645-8.
3. Thuong NT, Hélène C. Sequence-specific recognition and modification of double-helical DNA by oligonucleotides. Angew Chem Int Ed Engl 1993; 32: 666-90.
4. Le Doan T, Perrouault L, Praseuth D, et al. Sequence-specific recognition, photocrosslinking and cleavage of the DNA double helix by an oligo-[α]-thymidylate covalently linked to an azidoproflavine derivative. Nucleic Acids Res 1987; 19: 7749-60.
5. Beal PA, Dervan PB. Second structural motif for recognition of DNA by oligonucleotide-directed triple-helix formation. Science 1991; 251: 1360-3.
6. Durland RH, Kessler DJ, Gunnel S, Duvic M, Pettit BM, Hogan ME. Binding of triple helix forming oligonucleotides to sites in gene promoters. Biochemistry 1991; 30: 9246-55.
7. Eox KR. Targeting DNA with triplexes. Curr Med Chem 2000; 7: 17-37.
8. Seidman MM, Glazer PM. The potential for gene repair via triple helix formation. J Clin Invest 2003;112: 487-94.
9. Buchini S, Leumann CJ. Recent improvements in antigene technology. Curr Opin Chem Biol 2003; 7: 717-26.
10. n.d(TC) sequences. J Mol Evol 1988; 27: 96-101.
11. Behe MJ. An overabundance of long oligopurine tracts occurs in the genome of simple and complex eukaryotes. Nucleic Acids Res 1995; 23: 689-95.
12. Goni JR, de la Cruz X, Orozco M. Triplex-forming oligonucleotide target sequences in the human genome. Nucleic Acids Res 2004; 32: 354-60.
13. Goni JR, Vaquerizas JM, Dopazo J, Orozco M. Exploring the reasons for the large density of triplex-forming oligonucleotide target sequences in the human regulatory regions. BMC Genomics 2006; 7: 63-73.
14. Wu Q, Gaddis SS, MacLeod MC, et al. High affinity triplex-forming oligonucleotide target sites in mammalian genomes. Molecular Carcinogenesis. DOI 10.1002/mc.20261. Mol Carcinogen 2007; 46: 15-23.
15. Bacolla A, Collins JR, Gold B, et al. Long homopurine•homopyrimidine sequences are characteristic of genes expressed in brain and the pseudoautosomal region. Nucleic Acids Res 2006; 34: 2663-75.
16. Gaddis SS, Wu Q, Thames HD, et al. A web-based search engine for triplex-forming oligonucleotide target sequences. Oligonucleotides 2006; 16: 196-201.
17. Cooney M, Czernuszewicz G, Postel EH, Flint SJ, Hogan ME. Site-specific oligonucleotide binding represses transcription of the human c-myc gene in vitro. Science 1988; 241: 456-9.
18. Duvel-Valentin G, Thuong NT, Hélène C. Specific inhibition of transcription by triple helix-forming oligonucleotides. Proc Natl Acad Sci USA 1992; 89: 504-8.
19. Blume SW, Gee JE, Shrestha K, Miller DM. Triple helix formation by purine-rich oligonucleotides targeted to the human dihydrofolate reductase promoter. Nucleic Acids Res 1992; 20: 1717-84.
20. Mayfield C, Ebbinghaus S, Gee J, et al. Triplex formation by the human Ha-ras promoter inhibits Sp1 binding and in vitro transcription. J Biol Chem 1994; 269: 18232-38.
21. Maher JL, Dervan PB, Wold B. Analysis of promoter-specific repression by triple-helical DNA complexes in a eukaryotic cell-free transcription system. Biochemistry 1991; 31: 70-81.
22. Bednarski D, Firestine SM. Regulation of transcription by synthetic DNA-bending agents. Chembiochem 2006; 7: 1715-21.
23. Neurath MF, Max EE, Strober W. Pax (BSAP) regulates the murine immunoglobulin 3′ a enhancer by suppressing binding of NF-aP, a protein that controls heavy chain transcription. Proc Natl Acad Sci USA 1995; 92: 5336-40.
24. Westin L, Blomquist P, Milligan JF, Wrange O. Triple helix DNA alters nucleosomal histone-DNA interactions and acts as a nucleosome barrier. Nucleic Acids Res 1995; 23: 2184-91.
25. Ing NH, Beckman JM, Kessler DJ, et al. In vivo transcription of a progesterone-responsive gene is specifically inhibited by a triplex-forming of oligonucleotide. Nucleic Acids Res 1993; 21: 2789-96.
26. Grigoriev M, Praseuth D, Robin P, et al. A triple helix-forming oligonucleotide-intercalator conjugate acts as a transcriptional repressor via inhibition of NF κB binding to interleukin-2 receptor α-regulatory sequence. J Biol Chem 1992; 267: 3389-95.
27. Lavrosky Y, Mastyugin V, Stoltz RA, Abraham NG. Specific inbibition of c-fos proto-oncogen expression by triple-helix forming oligonucleotides. J Cell Biochem 1996; 61: 301-9.
28. Kovacs A, Kandala JC, Weber KT, Guntaka RV. Triple helix-forming oligonucleotide corresponding to the polypyrimidine sequence in the Rat α1 (I) collagen promoter specifically inhibits factor binding and transcription. J Biol Chem 1996; 271: 1805-12.
29. Joseph J, Kandala JC, Veerapanane D, Weber KT, Guntaka, RV. Antiparallel polypurine phosphorothioate oligonucleotides form stable triplexes with the rat α1 (I) collagen gene promoter and inhibit transcription in cultured rat fibroplasts. Nucleic Acids Res 1997; 25: 2182-88.
30. Cogoi S, Suraci C, Del Terra E, et al. Downregulation of c-ki-ras promoter activity by triplex-forming oligonucleotides endogenously generated in human 293 cells. Antisense Nucleic Acid Drug Dev 2000; 10: 283-95.
31. Stutz AM, Hoeck J, Natt F, Cuenod B, Woisetschlager M. Inhibition of interleukin-4 and CD40-induced IgE germline gene promoter activity by 2-aminoethoxy-modified triplex-forming oligonucleotides. J Biol Chem 2001; 276: 11759-65.
32. Lacroix L, Lacoste J, Reddoch JF, et al. Triplex formation by oligonucleotides containing 5-(1-propynyl)-2′-deoxyuridine. Decreased magnesium dependence and improved intracellular gene targeting. Biochemistry 1999; 38: 1893-1901.
33. Bailey C, Weeks DL. Understanding oligonucleotide-mediated inhibition of gene expression in Xenopus laevis oocytes. Nucleic Acids Res 2000; 28: 1154-61.
34. Faria M, Wood CD, White MR, Hélène C, Giovannangeli C. Transcription inhibition induced by modified triple helix-forming oligonucleotides: a quantitative assay for evaluation in cells. J Mol Biol 2001; 306: 15-24
35. Macris MA, Glazer PM. Transcription dependence of chromosomal gene targeting by triplex-forming oligonucleotides. J Biol Chem 2003; 278: 3357-62.
36. Brunet E, Alberti P, Perrouault L, Babu R, Wengel J, Giovannangeli C. Exploring cellular activity of locked nucleic acid-modified triplex-forming oligonucleotides and defining its molecular basis. J Biol Chem 2005; 280: 20076-85.
37. Brunet E, Corgnali M, Cannata F, Perrouault L, Giovannangeli C. Targeting chromosomal sites with locked nucleic acid-modified triplex-forming oligonucleotides: study of efficiency dependence on DNA nuclear environment. Nucleic Acids Res 2006; 34: 4546-53.
38. Michelotti EF, Tomonaga T, Krutzsch H, Levens D. Cellular nucleic acid acid binding protein regulates the CT element of the human c-myc protooncogene. J Biol Chem 1995; 270: 9494-99.
39. Giovannangeli C, Diviacco S, Labrousse V, Gryaznov S, Chameau P, Hélène C. Accessibility of nuclear DNA to triplex-forming oligonucleotides: the integrated HIV-1 provirus as a target. Proc Natl Acad Sci USA 1997; 94: 79-84.
40. Cogoi S, Ballico M, Bonora G-M, Xodo LE, Antiproliferative activity of a triplex-forming oligonucleotide recognizing a Ki-ras polypurine/ polypyrimidine motif correlates with protein binding. Cancer Gene Ther 2004, 11: 465-76.
41. Becker NA, Maher LJ. LMPCR Tor detection of oligonucleotide-directed triple helix formation: a cautionary note. Antisense Nucleic Acid Drug Dev 1999; 9: 313-6.
42. Orson FM, Thomas DW, McShan WM, Kessler DJ, Hogan ME. Oligonucleotide inhibition of IL2Rα mRNA transcription by promoter region colinear triplex formation in lymphocytes. Nucleic Acids Res 1991; 19: 3435-41.
43. Postel EH, Flint SJ, Kessler DJ, Hogan ME. Evidence that a triplex-forming oligodeoxyribonucleotide binds to the c-myc promoter in HeLa cells, thereby reducing c-myc mRNA levels. Proc Natl Acad Sci USA 1991; 88: 8227-31.
44. McGuffie EM, Pacheco D, Carbone GM, Catapano CV. Antigen and antiproliferative effects of a c-myc-targeting phosphothioate triple helix-forming oligonucleotide in Human Leukemia cells. Cancer Res 2000; 60: 3790-99.
45. Scaggiante B, Morassutti C, Tolazzi G, Michelutti A, Baccarani M, Quadrifoglio F. Effect of unmodified triple helix-forming oligodeoxyribonucleotide targeted to human multidrug-resistance gene mdr1 in MDR cancer cell: FEBS Lett 1994; 380-4.
46. Besch R, Giovannangeli C, Kammerbauer C, Degitz K. Specific inhibition of ICAM-1 expression mediated by gene targeting with triplex-forming oligonucleotides. J Biol Chem 2002; 277: 32473-79.
47. Carbone GM, McGuffie E, Napoli S, et al. DNA binding and antigene activity of a daunomycin-conjugated triplex-forming oligonucleotide targeting the P2 promoter of the human c-myc gene. Nucleic Acids Res 2004; 32: 2396-2410.
48. Besch R, Giovannangeli C, Schuh T, Kammerbauer C, Degitz K. Characterization and quantification of triple helix formation in chromosomal DNA. J Mol Biol 2004; 341: 979-89.
49. Napoli S, Negri U, Arcamone F, Capobianco ML, Carbone GM, Catapano CV. Growth inhibition and apoptosis induced by daunomycin-conjugated triplex-forming oligonucleotides targeting the cmyc gene in prostate cancer cells. Nucleic Acids Res 2006; 34: 1721-34.
50. Brown PM, Fox KR. Nucleosome core particles inhibit DNA triple helix formation. Biochem J 1996; 319: 607-11.
51. n sequences prevents nucleosome assembly and is hindered by nucleosomes. J Biol Chem 1996; 271: 31807-12.
52. Brown PM, Madden CA, Fox KR. Triple-helix formation at different positions on nucleosomal DNA. Biochemistry 1998; 37: 16139-51.
53. Brown PM, Fox KR. DNA triple-helix formation on nucleosome core particles: effect of length of the oligopurine tract. Eur J Biochem 1999; 261: 301-10.
54. Majumdar A, Puri N, Cuenoud B, et al. Cell cycle modulation of gene targeting by a triple helix-forming oligonucleotide. J Biol Chem 2003; 278: 11072-77.
55. Shevelev A, Burfeind P, Schulze E, et al. Potential triple helix-mediated inhibition of IGF-I gene expression significantly reduces tumorigenicity of glioblastoma in an animal model. Cancer Gene Ther 1997; 4: 102-5.
56. Rininsland F, Johnson TR, Chernicky CL, et al. Suppression of insulin-like growth factor type I receptor by a triple-helix strategy inhibits IGF-I transcription and tumorigenic potential of rat C6 glioblastoma cells. Proc Natl Acad Sci USA 1997; 94: 5854-9.
57. Re RN, Cook JL, Giardina JF. The inhibition of tumour growth by triplex-forming oligonucleotides. Cancer Lett 2004; 209: 51-3.
58. Ebbinghaus SW, Fortinberry H, Gamper HB. Inhibition of transcription elongation in the HER-2/neu coding sequence by triplex directed covalent modification of the template strand. Biochemistry 1999; 38, 619-28.
59. Young SL, Krawczyk SH, Matteucci MD, Toole JJ. Triple helix formation inhibits transcription elongation in vitro. Proc Natl Acad Sci USA 1991; 10023-26.
60. Wang Z, Rana TM. RNA damage-dependent transcriptional arrest and termination of RNA polymerase II elongation complexes in DNA template containing HIV-1 promoter. Proc Natl Acad Sci USA 1997; 6688-93.
61. Shen C, Buck A, Mehrke G, et al. Triplex forming oligonucleotide targeted to 3′-UTR, downregulates the expression of the bcl-2 proto-oncogene in HeLa cells. Nucleic Acids Res 2001; 29: 622-8.
62. Faria M, Wood CD, Perrouault L, et al. Targeted inhibition of transcription elongation in cells mediated by triplex-forming oligonucleotides. Proc Natl Acad Sci USA 2000; 97: 3862-67.
63. Giovannangeli C, Thuong NT, Hélène C. Oligonucleotide clamps arrest DNA synthesis on a single-stranded target. Proc Natl Acad Sci USA 1993; 90: 10013-7.
64. Hacia JG, Dervan PB, Wold BJ. Inhibition of klenow fragment DNA polymerase on double-helical templates by oligonucleotide-directed triple-helix formation. Biochemistry 1994; 33: 6192-200.
65. Samadashwily GM, Mirkin SM. Trapping DNA polymerase using triplex-forming oligodeoxyribonucleotides. Gene 1994; 149: 127-36.
66. Morassutti C, Scaggiante B, Xodo LE, et al. Reduction of mdr1 gene amplification in human multidrug resistant LoVo DX cell line is promoted by triple helix-forming oligonucleotides. Antisense Nucleic Acid Drug Dev 1999; 9: 261-70.
67. Diviacco S, Rapozzi V, Xodo L, Hélène C, Quadrifoglio F, Giovannangeli C. Site-directed inhibition of DNA replication by triple helix formation. FASEB J 2001; 15: 2660-8.
68. Maine IP, Kodadek T. Efficient unwinding of triplex DNA by a DNA helicase. Biochem Biophys Res Commun 1994; 204: 1119-24.
69. Reardon JT, Spielmann P, Huang JC, Sastry S, Sancar A, Hearst JE. Removal of psoralen monoadducts and crosslinks by human cell free extracts. Nucleic Acids Res 1991; 19: 4623-9.
70. Bianco PR, Tracey RB, Kowalczykowski SC. DNA strand exchange proteins: a biochemical and physical comparison. Front Biosci 1998; 3: 570-603
71. de Laat WL, Jaspers NG, Hoeijmakers JH. Molecular mechanism of nucleotide excision repair. Genes Dev 1999; 13: 768-85.
72. Batty DP, Wood RD. Damage recognition in nucleotide excision repair of DNA. Gene 2000; 241: 193-204.
73. Vasquez KM, Marburger Y, Intody Z, Wilson JH. Manipulating the mammalian genome by homologous recombination. Proc Natl Acad Sci USA 2001; 98: 8403-10.
74. Sandor Z, Bredberg A. Triple helix directed psoralen adducts induce a low frequency of recombination in an SV40 shuttle vector. Biochim Biophys Acta 1995; 1263: 235-40.
75. Luo Z, Macris MA, Faruqi AF, Glazer PM. High-frequency intrachromosomal gene conversion induced by triplex-forming oligonucleotides microinjected into mouse cells. Proc Natl Acad Sci USA 2000; 97: 9003-8.
76. Faruqi AF, Seidman MM, Segal DJ, Carroll D, Glazer PM. Recombination induced by triple-helix-targeted DNA damage in mammalian cells. Mol Cell Biol 1996; 16: 6820-8.
77. Faruqi AF, Datta HJ, Carroll D, Seidman MM, Glazer PM. Triple-helix formation induces recombination in mammalian cells via a nucleotide excision repair-dependent pathway. Mol Cell Biol 2000; 20: 990-1000.
78. Sandor Z, Bredberg A. Repair of triple helix directed psoralen adducts in human cells. Nucleic Acids Res 1994; 22: 2051-56.
79. Vasquez KM, Wang G, Havre PA, Glazer PM. Chromosomal mutations induced by triplex-forming oligonucleotides in mammalian cells. Nucleic Acids Res 1999; 27: 1176-81.
80. Sandor Z, Bredberg A. Deficient DNA repair of triple helix-directed double psoralen damage in human cells. FEBS Lett 1995; 374: 287-91.
81. Wang G, Glazer PM. Altered repair of targeted psoralen photoadducts in the context of an oligonucleotide-mediated triple helix. J Biol Chem 1995; 270: 22595-601.
82. Barre FX, Giovannangeli C, Hélène C, Harel-Bellan A. Covalent crosslinks introduced via a triple helix-forming oligonucleotide coupled to psoralen are inefficiently repaired. Nucleic Acids Res 1999; 27: 743-9.
83. Barre FX, Asseline U, Harel-Bellan A. Asymmetric recognition of psoralen interstrand crosslinks by the nucleotide excision repair and the error-prone repair pathways. J Mol Biol 1999; 286: 1379-87.
84. Nagatsugi F, Sasaki S, Miller, PS, Seidman MM. Site-specific mutagenesis by triple helix-forming oligonucleotides containing a reactive nucleoside analog. Nucleic Acids Res 2003; 31: e31.
85. 125I-labeled triplex-forming oligonucleotides conjugated with nuclear localization signal peptide. Antisense Nucleic Acid Drug Dev 2002; 12: 43-9.
86. Sedelnikova OA, Panyutin IV, Neumann RD, Bonner WM, Panyutin IG. Assessment of DNA damage produced by 125I-triplex-forming oligonucleotides in cells. Int J Radiat Biol 2004; 80: 927-31.
87. 111In-labelled triplex-forming oligonucleotide targeting N-myc gene. Mol Cells 2004; 14: 93-100.
88. Wang G, Seidman MM, Glazer PM. Mutagenesis in mammalian cells induced by triple helix formation and transcription-coupled repair. Science 1996; 271: 802-5.
89. Vasquez KM, Narayanan L, Glazer PM. Specific mutations induced by triplex-forming oligonucleotides in mice. Science 2000; 290: 530-3.
90. Knauert MP, Lloyd JA, Rogers FA, et al. Distance and affinity dependence of triplex-induced recombination. Biochemistry 2005; 44: 3856-64.
91. Robles J, Grandas A, Pedroso E, Luque FJ, Erijita R, Orozco M. Nucleic acid triple helices: stability effects of nucleobase modifications. Curr Org Chem 2002; 6: 1333-68.
92. Buchini S, Leumann CJ. Stable and selective recognition of three base pairs in the parallel triple-helical DNA binding motif. Angew Chem 2004; 116: 4015-18.
93. Rusling DA, Brown T, Fox KR. DNA recognition by triplex formation, In: Sequence-specific DNA binding agents. RSC publishing 2006; 1-28.
94. Kalish JM, Seidman MM, Weeks DL, Glazer PM. Triplex-induced recombination and repair in the pyrimidine motif. Nucleic Acids Res 2005; 33: 3492-502.
95. Roberts RW, Crothers DM. Prediction of the stability of DNA triplexes. Proc Natl Acad Sci USA 1992; 93: 4320-25.
96. Shimizu M, Konishi A, Shimada Y, Inoue H, Oshtsuka E. Oligo(2′-O-methyl) ribonucleotides: effective probes for duplex DNA. FEBS Lett 1992; 302: 155-8.
97. Escudé C, Sun J-S, Rougée M, Garestier T, Hélène C. Stable triple helices are formed upon binding of RNA oligonucleotides and their 2′-O-methyl derivatives to double helical DNA. Acad Sci III 1992; 315: 521-5.
98. Asensio JL, Carr R, Brown T, Lane AN. Conformational and thermodynamic properties of parallel intramolecular triple helixes containing a DNA, RNA, or 2′-O-Me DNA third strand. J Am Chem Soc 1999; 121: 11063-70.
99. Singh SK, Nielsen P, Koshkin AA, Wengel J. Locked nucleic acid: synthesis and high affinity nucleic acid recognition. Chem Commun 1999; 455-6.
100. Torigoe H, Hari Y, Sekiguchi M, Obika S, Imanishi T. 2′-O-,4′-C methylene bridged nucleic acid modification promotes pyrimidine motif triplex DNA formation at physiological pH. J Biol Chem 2001; 276: 2354-60.
101. Sun B-W, Babu R, Sørensen MD, Zakrzewska K, Wengel J, Sun J-S. Sequence and pH effects of LNA-containing triple helix-forming oligonucleotides: physical chemistry, biochemistry, and modelling studies. Biochemistry 2004; 43: 4160-69.
102. Plavec J, Thibeaudeau C, Chattopadhyaya. How does the 2′-hydroxy group drive the pseudorotational equilibrium in nucleoside and nucleotide by the tuning of the 3′-gauche effect? J Am Chem Soc 1994; 116: 6558-60.
103. Majumdar A, Khorlin A, Dyatkina N, et al. Targeted gene knockout mediated by triple-helix forming oligonucleotides. Nat Genet 1998; 20: 212-4.
104. Puri N, Majumdar A, Cuenoud B, et al. Targeted gene knockout by 2′-O-aminoethyl modified triplex forming oligonucleotides. J Biol Chem 2001; 276: 28991-98.
105. Cuenod B, Casset F, Hüsken D, et al. Dual recognition of double-stranded DNA by 2′-aminoethoxy-modified oligonucleotides. Angew Chem Int Ed 1998; 37: 1288-91.
106. Puri N, Majumdar A, Cuenoud B, Miller PS, Seidman MM. Importance of clustered 2′-O-(2-aminoethyl) residues for the gene targeting activity of triple helix-forming oligonucleotides. Biochemistry 2004; 43: 1343-51.
107. Seidman MM, Púri N, Majumdar A, Cuenod B, Miller PS, Rowshon A. The development of bioactive triple helix-forming oligonucleotides. Ann NY Acad Sci 2005; 1058: 119-27.
108. Lacoste J, Francois J-C, Hélène C. Triple helix formation with purine-rich phosphorothioate-containing oligonucleotides covalently linked to an acridine derivative. Nucleic Acids Res 1997; 25: 1991-8
109. Lown JW. Anthracycline and anthraquinone anticancer agents: current status and recent developments. Pharmacol Ther 1993; 60: 185-214.
110. Frederick CA, Williams LD, Ughetto G, et al. Structural comparison of anticancer drug-DNA complexes: adriamycin and daunomycin. Biochemistry 1990; 29: 2538-49.
111. Capobianco ML, De Champdore M, Francini L, Lena S, Garbesi A, Arcamone F. New TFO conjugates containing a carminomycinone-derived chromophore. Bioconjg Chem 2001; 12: 523-8.
112. Lee JS, Woodsworth ML, Latimer LJP, Morgan AR. Poly(pyrimidine).poly(purine) synthetic DNAs containing 5-methylcytosine form stable triplexes at neutral pH. Nucleic Acids Res 1984; 12: 6603-14.
113. Povsic TJ, Dervan PB. Triple helix formation by oligonucleotides on DNA extended to the physiological pH range. J Am Chem Soc 1989; 111: 3059-61.
114. Xodo LE, Manzini G, Quadrifoglio F, van der Marel GA, Boom JH. Effect of 5-methylcytosine on the stability of triple-stranded DNA- a thermodynamic study. Nucleic Acids Res 1991; 20: 5625-31.
115. Leitner D, Schröder W, Weisz K. Influence of sequence-dependant cytosine protonation and methylation on DNA triplex stability. Biochemistry 2000; 39: 5886-92.
116. Shahid KA, Majumdar A, Alam R, et al. Targeted cross-linking of the human β-globin gene in living cells mediated by a triple helix forming oligonucleotide. Biochemistry 1995; 45: 1970-78.
117. Ye Z, Cheng K, Guntaka RV, Mahato RI. Receptor-mediated hepatic uptake of M6P-BSA-conjugated triplex-forming oligonucleotides in rats. Bioconjug Chem 2006; 17: 820-830.
118. Gryaznov SM, Lloyd DH, Chen JK, et al. Oligonucleotide N3′ - >P5′ phosphoramidates. Proc Natl Acad Sci USA 1995; 92: 5798-5802.
119. Rapozzi V, Cogoi S, Spessotto P, et al. Antigene effect in K562 cells of a PEG-conjugated triplex-forming oligonucleotide targeted to the bcr/abl oncogene. Biochemistry 2002; 41: 502-10
120. Rogers FA, Manoharan M, Rabinovitch P, Ward DC, Glazer PM. Peptide conjugates for chromosomal gene targeting by triplex-forming oligonucleotides. Nucleic Acids Res 2004; 32: 6595-6604.
121. Kautz K, Schwarz M, Radeke HH. Interference with MCP-1 gene expression by vector generated triple helix-forming RNA oligonucleotides. Cell Mol Life Sci 2005; 62: 362-76.
122. Li JS, Fan YH, Zhang Y, Marky LA, Gold B. Design of triple helix forming C-glycoside molecules. J Am Chem Soc 2003; 125: 2084-93.
123. Guinvarc'h D, Fourrey J, Maurisse R, Sun J, Benhida R (2001) Incorporation of a novel nucleobase allows stable oligonucleotides-directed triple helix formation at the target sequence containing a purine.pyrimidine interruption. Chem Commun 2001: 1814-5.
124. Prevot-Halter I, Leumann CJ. Selective recognition of a C-G base-pair in the parallel DNA triple-helical binding motif. Bioorg Med Chem Lett 1999; 9: 2657-60.
125. Wang Y, Rusling DA, Powers VE, et al. Stable recognition of TA interruptions by triplex forming oligonucleotides containing a novel nucleoside. Biochemistry 2005; 44: 5884-92.
126. Osborne SD, Rowers VE, Rusling DA, Lack O, Brown T, Fox KR. Selectivity and affinity of triplex-forming oligonucleotides containing 2′-aminoethoxy-5-(3-aminoprop-1-ynyl)uridine for recognizing AT base pairs in duplex DNA. Nucleic Acids Res 2004; 32:4439-47.
127. Ranasinghe RT, Rusling DA, Powers VEC, Fox KR, Brown T, Recognition of CG inversions in DNA triple helices by methylated 3H-pyrollo[2,3-d]pyrimidin-2-one nucleoside analogues. Chem Commun 2005: 2555-7.
128. Rusling DA, Powers VEC, Ranasinghe RT, et al. Four base recognition by triplex-forming oligonucleotides at physiological pH. Nucleic Acids Res 2005; 33: 3025-32.
129. Hildbrand S, Leumann C. Enhancing DNA triple helix stability at neutral pH by the use of oligonucleotides containing a more basic deoxycytidine analog. Angew Chem Int Ed Engl 1996; 35: 1968-70.
130. Rusling DA, Le Strat L, Powers VEC, et al. Combining nucleoside analogues to achieve recognition of oligopurine tracts by triplex-forming oligonucleotides at physiological pH. FEBS Lett 2005; 579: 6616-20.
131. Darby RAJ, Fox KR. Triple-helix-specific ligands. In: Interaction of small molecules with DNA and RNA: From synthesis to nucleic acid complexes. Ed. Demeunynck M, Bailly C, Wilson, WD. Wiley-VCH, NJ, 2002, Chapter 14, p. 360-83.
132. Strekowski L, Say M, Zegrocka O, et al. Bis-4-aminoquinolines: Novel triple-helix DNA intercalators and antagonists of immunostimulatory CpG-oligodeoxynucleotides. Bioorg. Med. Chem. 2003; 11: 1079-85.
133. Strekowski L, Hojjat M, Wolinska E, et al. New triple-helix DNA stabilizing agents. Bioorg. Med. Chem. Lett. 2005; 15: 1097-1100.
134. Wheelhouse RT, Jennings SA, Phillips VA, et al. Design, synthesis, and evaluation of novel biarylpyrimidines: A new class of ligand for unusual nucleic acid structures. J Med Chem 2006; 49: 5187-98.
135. Chaires JB, Ren J, Hamelberg D, et al. Structural selectivity of aromatic diamidines. J Med Chem 2004; 47: 5729-42.
136. Chaires JB, Ren JS, Henary M, Zegrocka O, Bishop GR, Strekowski L. Triplex selective 2-(2-naphthyl)quinoline compounds: Origins of affinity and new design principles. J Am Chem Soc 2003; 125: 7272-83.
137. Vinogradov S, Roig V, Sergueeva Z, et al. Synthesis and binding properties of oligo-2′-deoxyribonucleotides conjugated with triple-helix-specific intercalators: Benzo[e] and benzo(g) pyridoindoles. Bioconjug Chem 2003; 14: 120-35.
138. Arya DP, Micovic L, Charles I, Coffee RL, Willis B, Xue L. Neomycin binding to Watson-Hoogsteen (W-H) DNA triplex groove: A model. J Am Chem Soc 2003; 125: 3733-44.
139. Napoli S, Carbone GM, Catapano CV, Shaw N, Arya DP. Neomycin improves cationic lipid-mediated transfection of DNA in human cells. Bioorg. Med Chem Lett 2005; 15: 3467-9.